So-Young International (NASDAQ:SY) Posts Earnings Results, Beats Expectations By $0.03 EPS

So-Young International (NASDAQ:SY) released its earnings results on Friday. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.03, Zacks reports. The business had revenue of $62.77 million during the quarter, compared to analyst estimates of $60.20 million. So-Young International had a negative net margin of 15.97% and a negative return on equity of 12.54%.

Here are the key takeaways from So-Young International’s conference call:

• So-Young reported Q1 2026 revenue of RMB 432.8 million, up 45.6% year over year, with aesthetic treatment services revenue rising 185.8% to RMB 282.4 million and exceeding the high end of guidance for the fourth straight quarter.
• The company’s clinic chain continued to scale quickly, reaching 59 centers across 17 cities by today, with Q1 treatment visits up 172% year over year and verified treatments up 164% year over year.
• Unit economics improved further, with 41 centers profitable and 48 generating positive operating cash flow in Q1. Management also said the aesthetic center business gross margin reached 27%, reflecting better operating efficiency.
• Management highlighted strong user engagement, including core members above 63,000 and referral-sourced new customers rising to 52% of the mix, while emphasizing that CAC remained well controlled.
• The company raised its supply-chain and product strategy, including an exclusive partnership with Jinbo Bio-Pharmaceutical and the launch of Miracle Collagen, while blockbuster products such as BBL and Thermage lifted blockbuster-product revenue contribution to 41% of Q1 sales.

So-Young International Price Performance

SY traded down $0.42 during trading on Friday, reaching $2.26. 959,453 shares of the stock traded hands, compared to its average volume of 524,066. The stock’s 50-day simple moving average is $2.88 and its two-hundred day simple moving average is $3.01. So-Young International has a fifty-two week low of $0.82 and a fifty-two week high of $6.28. The stock has a market cap of $228.72 million, a price-to-earnings ratio of -6.85 and a beta of 2.10.

Hedge Funds Weigh In On So-Young International

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. HRT Financial LP bought a new stake in So-Young International in the fourth quarter worth approximately $32,000. Virtu Financial LLC bought a new position in shares of So-Young International during the 4th quarter valued at $33,000. Dimensional Fund Advisors LP bought a new position in shares of So-Young International during the 3rd quarter valued at $63,000. Marshall Wace LLP acquired a new stake in shares of So-Young International in the 4th quarter valued at $45,000. Finally, Millennium Management LLC acquired a new stake in shares of So-Young International in the 3rd quarter valued at $123,000. Institutional investors own 35.31% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on SY. Wall Street Zen upgraded So-Young International from a “sell” rating to a “hold” rating in a research report on Sunday, April 26th. Weiss Ratings lowered So-Young International from a “sell (d)” rating to a “sell (d-)” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $5.50.

About So-Young International

So-Young International Inc operates a leading digital marketplace and community platform focused on the medical aesthetic industry in China. Headquartered in Shanghai and founded in 2013, the company connects consumers seeking cosmetic treatments with a network of accredited clinics, licensed physicians and beauty service providers. Its online ecosystem offers a wealth of educational content, peer reviews and before-and-after galleries designed to help users make informed decisions about aesthetic procedures.

The company’s platform is accessible via web and mobile applications, where users can browse service packages, compare providers, read expert articles and schedule appointments directly through an integrated booking system.